Search research articles
Contact Us
Filters
Showing results (111-120 of 133) with videos related to
Page
of 14
Sort By:
Journal of Neuro-Oncology
|
July 19, 2022
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
Marguerite Müller, Oliver Winz, Robin Gutsche, et al.
Neuro-Oncology
|
March 11, 2024
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group
Norbert Galldiks, Timothy J Kaufmann, Philipp Vollmuth, et al.
Molecular Imaging and Biology
|
October 17, 2023
Assessment of Brain Tumour Perfusion Using Early-Phase <sup>18</sup>F-FET PET: Comparison with Perfusion-Weighted MRI
Christian P Filss, Julian Cramer, Saskia Löher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
Jan-Michael Werner, Johannes Weller, Garry Ceccon, et al.
Neuro-Oncology Advances
|
March 14, 2025
Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by <i>O</i>-(2-[<sup>18</sup>F]fluoroethyl)-l-tyrosine PET
Michel Friedrich, Jan-Michael Werner, Joachim P Steinbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 9, 2020
Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[<sup>18</sup>F]-fluoroethyl)-L-tyrosine PET
Elena K Bauer, Gabriele Stoffels, Tobias Blau, et al.
Neuro-Oncology
|
December 22, 2021
Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases
Anna-Katharina Meißner, Robin Gutsche, Norbert Galldiks, et al.
Nuklearmedizin. Nuclear Medicine
|
May 21, 2026
Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0
Henryk Barthel, Matthias Brendel, Nathalie Albert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2025
Borderline Findings in <i>O</i>-(2-[<sup>18</sup>F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice
Karl-Josef Langen, Gabriele Stoffels, Christian P Filss, et al.
Clinical Nuclear Medicine
|
January 14, 2025
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse
Garry S Ceccon, Jan-Michael Werner, Maximilian I Ruge, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 133) with videos related to
Sort By:
Page
of 14
Journal of Neuro-Oncology
|
July 19, 2022
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
Marguerite Müller, Oliver Winz, Robin Gutsche, et al.
Neuro-Oncology
|
March 11, 2024
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group
Norbert Galldiks, Timothy J Kaufmann, Philipp Vollmuth, et al.
Molecular Imaging and Biology
|
October 17, 2023
Assessment of Brain Tumour Perfusion Using Early-Phase <sup>18</sup>F-FET PET: Comparison with Perfusion-Weighted MRI
Christian P Filss, Julian Cramer, Saskia Löher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
Jan-Michael Werner, Johannes Weller, Garry Ceccon, et al.
Neuro-Oncology Advances
|
March 14, 2025
Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by <i>O</i>-(2-[<sup>18</sup>F]fluoroethyl)-l-tyrosine PET
Michel Friedrich, Jan-Michael Werner, Joachim P Steinbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 9, 2020
Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[<sup>18</sup>F]-fluoroethyl)-L-tyrosine PET
Elena K Bauer, Gabriele Stoffels, Tobias Blau, et al.
Neuro-Oncology
|
December 22, 2021
Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases
Anna-Katharina Meißner, Robin Gutsche, Norbert Galldiks, et al.
Nuklearmedizin. Nuclear Medicine
|
May 21, 2026
Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0
Henryk Barthel, Matthias Brendel, Nathalie Albert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2025
Borderline Findings in <i>O</i>-(2-[<sup>18</sup>F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice
Karl-Josef Langen, Gabriele Stoffels, Christian P Filss, et al.
Clinical Nuclear Medicine
|
January 14, 2025
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse
Garry S Ceccon, Jan-Michael Werner, Maximilian I Ruge, et al.
Page
of 14